Safety and efficacy of low dose intracoronary insulin-like growth factor 1 to prevent heart failure following percutaneous coronary intervention for acute myocardial infarction (RESUS-AMI).

29 April 2017 (08:40 - 08:47)
Organised by:
Congress Presentation Part of: Late Breaking Trials I: Focus on acute heart failure Acute Heart Failure HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

ESC 365 is supported by

ESC 365 is supported by